Found 109 matching trials
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC. PHASE2 This study is a multicenter, prospective, randomized, double-arm, Phase II ...
Show More Location
Dept. of Colorectal Surgery, Sun Yat-sen University Cancer Center. Yuexiu District, Dongfeng East Road 651
Learn More & Join Trial
Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer PHASE2 To evaluate the efficacy and safety of totally neoadjuvant FOLFOXIRI chemot...
Show More Location
China Medical University
Learn More & Join Trial
Liposomal Irinotecan, Capecitabine and Enlonstobart With Short-Course Radiotherapy for Locally Advanced Rectal Cancer PHASE2 This is a prospective, single-center, single-arm study evaluating the combi...
Show More Location
Tianjin Medical University Cancer Institute & Hospital
Learn More & Join Trial
Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION) PHASE3 The study is a multicenter, open-label, randomized controlled clinical stud...
Show More Status
Active Not Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer PHASE2 This study is a single-center, prospective, open-label, randomized controll...
Show More Location
Fourth Hospital of Hebei Medical University
Learn More & Join Trial
A Pilot Study Evaluating ฮฒ-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer PHASE2 This study is a prospective phase II clinical trial aimed at exploring the ...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Neoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma PHASE2 Neoadjuvant Short-Course Radiotherapy Followed by Tislelizumab Plus Chemoth...
Show More Location
Tangdu Hospital, Fourth Military Medical University
Learn More & Join Trial
Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial PHASE3 This is a randomized, controlled clinical trial based on prior exploratory ...
Show More Location
Guangdong Provincial People's Hospital
Learn More & Join Trial
SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer. PHASE2 SBRT Combined with CAPEOX, Bevacizumab, and PD-1 Inhibitor in RAS-Mutant, M...
Show More Location
Multiple Locations
Learn More & Join Trial